ATE241698T1 - Hst-2 mutein, dafür kodierende dns und herstellung - Google Patents

Hst-2 mutein, dafür kodierende dns und herstellung

Info

Publication number
ATE241698T1
ATE241698T1 AT94102093T AT94102093T ATE241698T1 AT E241698 T1 ATE241698 T1 AT E241698T1 AT 94102093 T AT94102093 T AT 94102093T AT 94102093 T AT94102093 T AT 94102093T AT E241698 T1 ATE241698 T1 AT E241698T1
Authority
AT
Austria
Prior art keywords
polypeptide
hst
production
dna coding
seq
Prior art date
Application number
AT94102093T
Other languages
English (en)
Inventor
Koji Yoshimura
Kaori Ishimaru
Koichi Igarashi
Masaaki Tereda
Original Assignee
Takeda Chemical Industries Ltd
President Of Nat Cancer Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd, President Of Nat Cancer Ct filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE241698T1 publication Critical patent/ATE241698T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94102093T 1993-02-12 1994-02-11 Hst-2 mutein, dafür kodierende dns und herstellung ATE241698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2439993 1993-02-12
JP18650793 1993-07-28

Publications (1)

Publication Number Publication Date
ATE241698T1 true ATE241698T1 (de) 2003-06-15

Family

ID=26361903

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94102093T ATE241698T1 (de) 1993-02-12 1994-02-11 Hst-2 mutein, dafür kodierende dns und herstellung

Country Status (5)

Country Link
US (2) US5679550A (de)
EP (1) EP0613946B1 (de)
AT (1) ATE241698T1 (de)
CA (1) CA2115522A1 (de)
DE (1) DE69432724T2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115522A1 (en) * 1993-02-12 1994-08-13 Takeda Pharmaceutical Company Limited Hst-2 mutein, dna coding for the same and preparation thereof
WO1998025634A1 (en) * 1996-12-10 1998-06-18 Hadasit Medical Research Services & Development Company Ltd. Serum-derived factor inducing cell differentiation and medical uses thereof
US10779958B2 (en) 2014-12-22 2020-09-22 Beacon Biomedical, Llc Sacroiliac joint fusion systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69018357T2 (de) * 1989-10-06 1995-09-21 President Of National Cancer C Mutein von HST-1 und seine Herstellung.
EP0488196A3 (en) * 1990-11-30 1993-04-07 Takeda Chemical Industries, Ltd. Hst-2, a member of the heparin binding growth factor family
JP3385040B2 (ja) * 1991-02-14 2003-03-10 武田薬品工業株式会社 グリア活性化因子およびその製造法
CA2115522A1 (en) * 1993-02-12 1994-08-13 Takeda Pharmaceutical Company Limited Hst-2 mutein, dna coding for the same and preparation thereof

Also Published As

Publication number Publication date
EP0613946A2 (de) 1994-09-07
CA2115522A1 (en) 1994-08-13
US6013784A (en) 2000-01-11
EP0613946B1 (de) 2003-05-28
EP0613946A3 (en) 1995-11-02
DE69432724D1 (de) 2003-07-03
DE69432724T2 (de) 2004-04-01
US5679550A (en) 1997-10-21

Similar Documents

Publication Publication Date Title
AU4880093A (en) Retrovirus from the HIV group and its use
DE3582732D1 (de) Herstellungsverfahren fuer erythropoietin.
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
EP0458959A4 (en) Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof
ATE130869T1 (de) Protein mit der aktivität vom typ von cytokin, dafür kodierende rekombinante dns, transformierte zellen und mikroorganismen.
DE69123106D1 (de) Polypeptid, das zur Interaktion mit Thrombin fähig ist
DK471386A (da) Farmaceutisk komposition til behandling af leukopeni
DK192189D0 (da) Polypeptid, fremgangsmaade til inhibering af fibrinogen, fremgangsmaade til rensning af et polypeptid, gen indeholdende rekombinante dna kodende for et polypeptid, vektor, cellekultur og fremgangsmaade til fremstilling af et cysteinrigt polypeptid
DE69120626D1 (de) Polypeptid
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
EP1501936A4 (de) Cytokin-proteinfamilie
EP1281763A3 (de) Early growth response-1 (EGR-1) transkriptions-faktor
DE69432724D1 (de) HST-2 Mutein, dafür kodierende DNS und Herstellung
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
EP0723016A3 (de) Leukocyten-aktivierender Faktor
DE69330348D1 (de) Verwendung von Peptiden welche eine Immunantwort bewirken zur Herstellung von Medikamenten zur Induzierung der Immunsuppression.
JPS5775960A (en) Purified polypeptide
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ATE141093T1 (de) Polypeptid
MX9504057A (es) Proteina que tiene actividad tpo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties